Skip to content

Clinical trials

Phase 2 Granulomatosis with Polyangiitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Granulomatosis with Polyangiitis Phase: Phase 2 Country / region: United States Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20131
20181
20191
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)5
Novartis Pharmaceuticals2
Hoffmann-La Roche1
InflaRx GmbH1
Mayo Clinic1
NYU Langone Health1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Granulomatosis with Polyangiitis12
Vasculitis6
Microscopic Polyangiitis5
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis3
Giant Cell Arteritis2
Recurrence2
Arthritis, Juvenile1
Arthritis, Psoriatic1
Arthritis, Rheumatoid1
Churg-Strauss Syndrome1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.